Q&A: TJU's Paolo Fortina on the Evolving Market for Genomic Research Tools

For Thomas Jefferson University's Paolo Fortina, second-generation sequencing and targeted resequencing are just the latest genomic research tools to be deployed to aid in the treatment of cancer. Now, like many lab directors, he has to decide where to put valuable resources in order to stay on top of the changing tools landscape.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.